000 01218 a2200313 4500
005 20250513095156.0
264 0 _c19960926
008 199609s 0 0 fre d
022 _a0929-693X
024 7 _a10.1016/0929-693x(96)86397-4
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAutret, E
245 0 0 _a[Should benefit-risk ratio of the intramuscular vitamin K be reevaluated in newborn infants?].
_h[electronic resource]
260 _bArchives de pediatrie : organe officiel de la Societe francaise de pediatrie
_cMay 1996
300 _a415-8 p.
_bdigital
500 _aPublication Type: Editorial; Review
650 0 4 _aAge Factors
650 0 4 _aHumans
650 0 4 _aInfant, Newborn
650 0 4 _aInjections, Intramuscular
650 0 4 _aNeoplasms
_xchemically induced
650 0 4 _aOdds Ratio
650 0 4 _aRisk Assessment
650 0 4 _aVitamin K
_xadministration & dosage
650 0 4 _aVitamin K Deficiency Bleeding
_xchemically induced
700 1 _aJonville-Bera, A P
773 0 _tArchives de pediatrie : organe officiel de la Societe francaise de pediatrie
_gvol. 3
_gno. 5
_gp. 415-8
856 4 0 _uhttps://doi.org/10.1016/0929-693x(96)86397-4
_zAvailable from publisher's website
999 _c8760573
_d8760573